Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- HPVIndependent statistical analysis of An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HPVIndependent statistical analysis of Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HPV Vaccine Intervention for Young Sexual Minority Men: Complete Statistical AnalysisIndependent statistical analysis of HPV Vaccine Intervention for Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032106).
- HREIndependent statistical analysis of Protonics Knee Brace Versus Hamstring Resisted Exercise (HRE) on Individuals With Patellofemoral Pain Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HRSA NutritionIndependent statistical analysis of Nutritional Status and Enteral Absorption Capability After Brain Death: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00858390).
- HRVIndependent statistical analysis of Heart Rate Variability in Trauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00795535).
- HRVB-SCTIndependent statistical analysis of Heart Rate Variability Biofeedback for Smoking Cessation Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05224050).
- HSCT for High Risk Inherited Inborn Errors: Complete Statistical AnalysisIndependent statistical analysis of HSCT for High Risk Inherited Inborn Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383448).
- HSDDIndependent statistical analysis of 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HSG and Tubal Patency Study: Complete Statistical AnalysisIndependent statistical analysis of HSG and Tubal Patency Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02146248).
- HSIIndependent statistical analysis of Home Safety Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06216327).
- HSPvsHSPASIIndependent statistical analysis of Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HSV1/HCVIndependent statistical analysis of Herpes Simplex Type 1 Suppression in Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580995).
- HUCSIndependent statistical analysis of Human Use Condition Study- Evaluation of Implanted Leads in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320849).
- HULKIndependent statistical analysis of Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HUM15709Independent statistical analysis of Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01190527).
- HUM21469Independent statistical analysis of Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130061).
- Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A: Complete Statistical AnalysisIndependent statistical analysis of Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02773446).
- Human Factor Validation of Pediatric Mobility Device: Complete Statistical AnalysisIndependent statistical analysis of Human Factor Validation of Pediatric Mobility Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714256).
- Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: Complete Statistical AnalysisIndependent statistical analysis of Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Human Lung Responses to Respiratory Pathogens: Complete Statistical AnalysisIndependent statistical analysis of Human Lung Responses to Respiratory Pathogens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01967628).
- Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals’ HPV-16/18: Complete Statistical AnalysisIndependent statistical analysis of Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00513526).
- Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: Complete Statistical AnalysisIndependent statistical analysis of Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Perception of Odors and Odor Blockers: Complete Statistical AnalysisIndependent statistical analysis of Human Perception of Odors and Odor Blockers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06191419).
- Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema: Complete Statistical AnalysisIndependent statistical analysis of Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HUMBOLDTIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Hummingbird TTS Ear Tube Delivery Study: Complete Statistical AnalysisIndependent statistical analysis of Hummingbird TTS Ear Tube Delivery Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165384).
- HUPKIndependent statistical analysis of Pharmacokinetics of Oral Hydroxyurea Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03763656).
- HVTN 120Independent statistical analysis of Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants: primary endpoint results, effect estimate with confidence interval,…
- HVTN 135Independent statistical analysis of Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants: primary endpoint results, effect estimate with confidence interval, sample-size…
- HVTN119Independent statistical analysis of Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA: primary endpoint results, effect estimate with confidence interval, sample-size…
- HVTN702Independent statistical analysis of Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- HY-GRAIDIndependent statistical analysis of Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04255381).
- Hyaluronidase Effect on Infusion Set Life: Complete Statistical AnalysisIndependent statistical analysis of Hyaluronidase Effect on Infusion Set Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02199028).
- HybridIndependent statistical analysis of A Comparison of Stryker Hybrid Arch Bars: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02283528).
- Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02463097).
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- HyCoSyIndependent statistical analysis of Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Hydration Factor Study for the Stayhealthy BC3: Complete Statistical AnalysisIndependent statistical analysis of Hydration Factor Study for the Stayhealthy BC3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01209936).
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902538).
- Hydrocortisone for BPD: Complete Statistical AnalysisIndependent statistical analysis of Hydrocortisone for BPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01353313).
- Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydromorphone vs Fentanyl in Children Undergoing Tonsillectomy Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04230681).
- Hydroxychloroquine and Cognitive Function After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Cognitive Function After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03025087).
- Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01573754).
- Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372017).